Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily M Ko

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology Reports|November 11, 2024
Cost of care associated with utilization of telehealth in clinical trialsEmily Gleason, Leslie Andriani, Elizabeth A Tubridy, et al.
Gynecologic Oncology|October 16, 2022
Prior authorization in gynecologic oncology: An analysis of clinical impactAnna Jo Bodurtha Smith, Lakeisha Mulugeta-Gordon, Daniella Pena, et al.
Gynecologic Oncology Reports|February 3, 2022
Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcomaLori Cory, Colleen Brensinger, Robert A Burger, et al.
Gynecologic Oncology|December 17, 2019
Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data BaseDimitrios Nasioudis, Nawar A Latif, Fiona Simpkins, et al.
Gynecologic Oncology|December 25, 2012
Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinomaJoshua E Kilgore, Amanda L Jackson, Emily M Ko, et al.
Gynecologic Oncology|December 12, 2022
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinomaDimitrios Nasioudis, Nawar A Latif, Emily M Ko, et al.
Gynecologic Oncology|November 29, 2023
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directionsDimitrios Nasioudis, Stefan Gysler, Nawar Latif, et al.
American Journal of Clinical Oncology|August 4, 2022
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and OutcomesDimitrios Nasioudis, Neil K Taunk, Emily M Ko, et al.
Gynecologic Oncology|May 4, 2020
Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapyDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2023
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgeryDimitrios Nasioudis, Xiaolei Wang, Gurdial Dhillon, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology Reports|November 11, 2024
Cost of care associated with utilization of telehealth in clinical trialsEmily Gleason, Leslie Andriani, Elizabeth A Tubridy, et al.
Gynecologic Oncology|October 16, 2022
Prior authorization in gynecologic oncology: An analysis of clinical impactAnna Jo Bodurtha Smith, Lakeisha Mulugeta-Gordon, Daniella Pena, et al.
Gynecologic Oncology Reports|February 3, 2022
Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcomaLori Cory, Colleen Brensinger, Robert A Burger, et al.
Gynecologic Oncology|December 17, 2019
Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data BaseDimitrios Nasioudis, Nawar A Latif, Fiona Simpkins, et al.
Gynecologic Oncology|December 25, 2012
Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinomaJoshua E Kilgore, Amanda L Jackson, Emily M Ko, et al.
Gynecologic Oncology|December 12, 2022
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinomaDimitrios Nasioudis, Nawar A Latif, Emily M Ko, et al.
Gynecologic Oncology|November 29, 2023
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directionsDimitrios Nasioudis, Stefan Gysler, Nawar Latif, et al.
American Journal of Clinical Oncology|August 4, 2022
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and OutcomesDimitrios Nasioudis, Neil K Taunk, Emily M Ko, et al.
Gynecologic Oncology|May 4, 2020
Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapyDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2023
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgeryDimitrios Nasioudis, Xiaolei Wang, Gurdial Dhillon, et al.
Pageof 13